This activity is specifically designed for:
Health and Non-health Sector Communities Engaged in Activities Impacted by COVID-19
Scientists
Decision Makers
Ministries of Health
At the end of the course, learners should be able to:
Describe how a platform for rapid collation and dissemination of the design, data and experiences of diagnostic-based interventions can slow the spread of Variants of Concern (VOCs) and save lives and livelihoods
Participate in a broader global health community of critical stakeholders, including the non-health sector, by sharing interventions that will guide re-opening of economies
Promote openness and sharing during pandemics in an effort to more quickly inform and change testing guidance and policies
Bringing together health and non-health sector stakeholders to keep updated on the use of testing in combination with other public health measures to guide best practices across regions as economies begin to open. In collaboration with key regional organizations such as Africa Centres for Disease Control & Prevention, Association of Southeast Asian Nations, Latin American Alliance for the Development of In Vitro Diagnostics, and International Diagnostic Centre/London School of Hygiene & Tropical Medicine. This course covers the following topics:
Moving from pandemic response to control: living with the virus
Updates on vaccines, variants of concerns and testing
A COVID-19 evidence co-op
Case studies: mass gatherings and travel
Professor Rosanna Peeling and Professor David Heymann are Co-directors for the course.
Professor Rosanna Peeling, London School of Hygiene & Tropical Medicine and International Diagnostic Centre, UK
Professor David Heymann, London School of Hygiene & Tropical Medicine, UK
Dr. Noah Fongwen, London School of Hygiene & Tropical Medicine and Africa Centres for Disease Control and Prevention
Dr. Donal Sammin, Department of Agriculture, Food & the Marine, Ireland
Professor Yap Boum II, Africa for Epicentre, Médecins sans Frontières, and University of Yaoundé, Cameroon
Professor YY Teo, Saw Swee Hock School of Public Health at the National University of Singapore
Carlos Gouvea, Latin American Alliance for In Vitro Diagnostic Development (ALLADiV), Brazil
Dr. Ilesh Jani, National Institute of Health, Mozambique
Dr. Robert Luo, Global Health Impact Group, US
Dr. Debi Boeras, Global Health Impact Group, US
Add your email to the mailing list to get the latest updates.
